Cargando…
A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling
Background: High mobility group box 1 (HMGB1)-receptor for advanced glycation endo-products (RAGE) axis serves as a key player in linking inflammation and carcinogenesis. Recently, papaverine was revealed to suppress the HMGB1-RAGE inflammatory signaling pathway and cancer cell proliferation. Theref...
Autores principales: | Abe, Hideaki, Okazawa, Miwa, Oyama, Takahiro, Yamazaki, Hiroaki, Yoshimori, Atsushi, Kamiya, Takanori, Tsukimoto, Mitsutoshi, Takao, Koichi, Sugita, Yoshiaki, Sakagami, Hiroshi, Abe, Takehiko, Tanuma, Sei-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064355/ https://www.ncbi.nlm.nih.gov/pubmed/33805209 http://dx.doi.org/10.3390/medicines8040017 |
Ejemplares similares
-
A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling
por: Tanuma, Sei-ichi, et al.
Publicado: (2022) -
A Comparative Study of Tumor-Specificity and Neurotoxicity between 3-Styrylchromones and Anti-Cancer Drugs
por: Abe, Tomoyuki, et al.
Publicado: (2023) -
Effects of 3-styrylchromones on metabolic profiles and cell death in oral squamous cell carcinoma cells
por: Sakagami, Hiroshi, et al.
Publicado: (2015) -
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors
por: Tanuma, Sei-ichi, et al.
Publicado: (2020) -
Styrylchromones: Biological Activities and Structure-Activity Relationship
por: Lucas, Mariana, et al.
Publicado: (2021)